Timothy C. Nichols

A phase II prospective open‐label escalating dose trial of recombinant interleukin‐11 in mild von Willebrand disease

M. Ragni, E. Merricks, R. Jankowitz, 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

Non-classical processes in surface hemostasis: mechanisms for the poly-N-acetyl glucosamine-induced alteration of red blood cell morphology and surface prothrombogenicity

E. Merricks, J. Vournakis, M. Demcheva, 2008, Biomedical materials.

Persistent expression of canine factor IX in hemophilia B canines

R. Samulski, D. Bellinger, T. Nichols, 1999, Gene Therapy.

An Observational Study from Long-Term AAV Re-administration in Two Hemophilia Dogs

R. Samulski, Chengwen Li, T. Nichols, 2018, Molecular therapy. Methods & clinical development.

Targeted Disruption of LDLR Causes Hypercholesterolemia and Atherosclerosis in Yucatan Miniature Pigs

D. Bellinger, T. Nichols, Xiao-jun Wang, 2014, PloS one.

Thrombotic thrombocytopenia induced in dogs and pigs. The role of plasma and platelet vWF in animal models of thrombotic thrombocytopenic purpura.

T. Nichols, R. Reddick, W. Sanders, 1995, Arteriosclerosis, thrombosis, and vascular biology.